NYSE : OSCR
Oscar Health, Inc. — Key statistics
Healthcare · Healthcare Plans · United States
Last price 30.37 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.36B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 9.36B |
| Enterprise Value | 5.77B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 273.15M |
| Shares Outstanding | 308.33M |
| Shares Change (YoY) | +17.37% |
| Shares Change (QoQ) | +1.12% |
| Owned by Insiders (%) | 3.85% |
| Owned by Institutions (%) | 62.32% |
| Float | 263.61M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 15.92 |
| Forward PE | 16.66 |
| PS Ratio | 0.61 |
| Forward PS | 0.47 |
| PB Ratio | 4.56 |
| P/TBV Ratio | 4.56 |
| P/FCF Ratio | 2.14 |
| P/OCF Ratio | 2.12 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 10.48 |
| EV / Sales | 0.38 |
| EV / EBITDA | 8.77 |
| EV / EBIT | 9.16 |
| EV / FCF | 1.32 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.08 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 0.72 |
| Debt / FCF | 0.11 |
| Interest Coverage | 39.73 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 34.26% |
| Return on Assets (ROA) | 4.47% |
| Return on Invested Capital (ROIC) | 25.10% |
| Return on Capital Employed (ROCE) | 24.82% |
| Weighted Average Cost of Capital (WACC) | 17.11% |
| Revenue Per Employee | $6.65M |
| Profits Per Employee | $238,934 |
| Employee Count | 2,305 |
| Asset Turnover | 1.74 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 38.88M |
| Effective Tax Rate | 6.59% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.47 |
| 52-Week Price Change | +60.60% |
| 50-Day Moving Average | 31.71 |
| 200-Day Moving Average | 23.60 |
| Relative Strength Index (RSI) | 41.48 |
| Average Volume (20 Days) | 4,618,504 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 18.29M |
| Short Previous Month | 17.77M |
| Short % of Shares Out | 5.93% |
| Short % of Float | 6.94% |
| Short Ratio (days to cover) | 3.35 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 15.32B |
| Gross Profit | 3.09B |
| Operating Income | 629.72M |
| Pretax Income | 589.81M |
| Net Income | 550.74M |
| EBITDA | 657.96M |
| EBIT | 629.72M |
| Earnings Per Share (EPS) | $1.91 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 8.56B |
| Total Debt | 482.10M |
| Net Cash | 3.59B |
| Net Cash Per Share | $11.65 |
| Equity (Book Value) | 2.06B |
| Book Value Per Share | 6.66 |
| Working Capital | 683.68M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 4.42B |
| Capital Expenditures | -38.63M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 371.12M |
| Free Cash Flow | 4.38B |
| FCF Per Share | $14.21 |
Margins
| Measure | Value |
|---|
| Gross Margin | 20.16% |
| Operating Margin | 4.11% |
| Pretax Margin | 3.85% |
| Profit Margin | 3.60% |
| EBITDA Margin | 4.30% |
| EBIT Margin | 4.11% |
| FCF Margin | 28.59% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -17.37% |
| Shareholder Yield | -17.37% |
| Earnings Yield | 6.28% |
| FCF Yield | 46.77% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $36.40 |
| Price Target Difference | 19.86% |
| Analyst Consensus | Hold |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 27.77% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |